Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2000
09/28/2000WO2000056352A2 Reagents and methods useful for detecting diseases of the prostate
09/28/2000WO2000056333A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
09/28/2000WO2000056158A1 Composition and methods for the treatment of cancer and viral infections
09/28/2000WO2000056135A2 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
09/28/2000WO2000042221A3 Method for the affinity isolation of newly synthesized rna
09/28/2000WO2000041610A3 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
09/28/2000WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
09/28/2000WO2000031253A3 Mutation of the parkin gene, compositions, methods and uses
09/28/2000WO2000029577A9 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
09/28/2000WO2000028312A9 A miniature support for thin films containing single channels or nanopores and methods for using same
09/28/2000WO2000028071A9 A method for the determination of homocysteine
09/28/2000WO2000026413A9 Determining signal transduction pathways
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000WO2000025807A9 Binding moieties for human parvovirus b19
09/28/2000WO2000024933A9 Detection of loss of heterozygosity in tumor and serum of melanoma patients
09/28/2000WO2000023576A3 Secretases related to alzheimer's dementia
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000020438A9 G protein-coupled receptor resembling the thrombin receptor
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000WO2000009464A9 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
09/28/2000WO1999067417A3 Fitness assay and associated methods
09/28/2000WO1999018234A3 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample
09/28/2000DE19913858A1 High-Throughput-Screening-Verfahren zur Bestimmung der Enantioselektivität asymmetrisch verlaufender Reaktionen High-throughput screening method for determining the enantioselectivity of asymmetric extending reactions
09/28/2000DE19913428A1 Verwendung von Kollagenase 3 zum Nachweis von destruktiven Gelenkerkrankungen, insbesondere zur Prognose des Krankheitsverlaufs und zur genetischen Prädisposition der Rheumatoiden Arthritis (RA) Use of collagenase 3 for detecting destructive joint diseases, in particular for prognostic and genetic predisposition of rheumatoid arthritis (RA)
09/28/2000DE19910956A1 Determining sensitivity of cells to apoptotic agents, useful e.g. for selecting compounds for treating cancer, by measurement of accumulated caspase activity
09/28/2000DE19910354A1 Detecting viral infection of germ cells, useful e.g. for isolating ova or sperm suitable for in vitro fertilization and for detecting male infertility
09/28/2000CA2814831A1 Hyphal growth in fungi
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2371987A1 Screening method involving mgdg synthase
09/28/2000CA2369533A1 Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction process
09/28/2000CA2368916A1 49 human secreted proteins
09/28/2000CA2368672A1 Genomic sequence of the purh gene and purh-related biallelic markers
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367504A1 A screening method for a cysteine protease inhibitor
09/28/2000CA2367471A1 Fungal beta-tubulin genes
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367125A1 Reagents and methods useful for detecting diseases of the prostate
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366565A1 Method of determining substrate, and biosensor
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2366509A1 Automated 2-dimensional analysis of biological and other samples
09/28/2000CA2366289A1 Solution-based methods and materials for sequence analysis by hybridization
09/28/2000CA2366267A1 49 human secreted proteins
09/28/2000CA2366249A1 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
09/28/2000CA2366237A1 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366211A1 Hyphal growth in fungi
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365981A1 Linear and circular expression elements
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2364607A1 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
09/27/2000WO2001016367A1 Methods for exogenous, internal controls during nucleic acid amplification
09/27/2000EP1038974A1 Method, oligonucleotides suitable for the degradation of in vitro synthezised nucleic acid molecules
09/27/2000EP1038973A1 Dna cycle sequencing
09/27/2000EP1038972A2 Method for investigating surfaces
09/27/2000EP1038965A1 Method of screening for chemical compounds capable of inducing ERS in plants
09/27/2000EP1038963A2 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038960A1 BSMAP, a surface protein expressed specifically in the brain
09/27/2000EP1038957A1 Tsa305 gene
09/27/2000EP1038939A1 Chemiluminescent reagents and chemiluminescence analysis methods with the use of the same
09/27/2000EP1038523A2 Method for identifying compounds for inhibition of neoplastic lesions
09/27/2000EP1038176A2 Embossed test strip system
09/27/2000EP1038171A1 Nanoelectrode arrays
09/27/2000EP1038037A1 Screening assays for the detection and diagnosis of influenza virus
09/27/2000EP1038036A1 Detection of hepatitis b virus
09/27/2000EP1038035A1 METHOD FOR IDENTIFYING $i(ESCHERICHIA COLI) STRAIN DSM 6601
09/27/2000EP1038034A1 Method for identifying nucleic acids by electro-spray mass spectrometry
09/27/2000EP1038033A2 High throughput assay system
09/27/2000EP1038032A1 Methods for making nucleic acids
09/27/2000EP1038031A1 Mass spectrometric methods for sequencing nucleic acids
09/27/2000EP1038029A2 Universal collection medium
09/27/2000EP1038028A2 Methods and reagents for preservation of dna in bodily fluids
09/27/2000EP1038027A1 Decreasing cell proliferation by decreasing levels of pp5
09/27/2000EP1038026A1 Diagnostic assay for cancer susceptibility
09/27/2000EP1038025A1 Genetic alterations associated with cancer
09/27/2000EP1038024A1 Stabilised reagent and method for determining creatine kinase
09/27/2000EP1038023A1 Agonists of metabotropic glutamate receptors and uses thereof
09/27/2000EP1038022A2 Assessment of human papilloma virus-related disease
09/27/2000EP1038020A1 Secreted protein nsl4
09/27/2000EP1038017A2 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families
09/27/2000EP1038015A2 Mood disorder gene
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1038009A1 Methods for defining cell types
09/27/2000EP1038008A2 Egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
09/27/2000EP1038003A1 Cyclic gmp phosphodiesterase
09/27/2000EP1038002A1 Ubiquitin-like conjugating protein
09/27/2000EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides
09/27/2000EP1037998A1 guaA POLYPEPTIDES
1 ... 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 ... 3003